An FDA-approved iron oxide nanoparticle used for the treatment of anaemia can be repurposed for leukaemia therapy.
References
Crichton, R. in Iron Metabolism: From Molecular Mechanisms to Clinical Consequences (ed. Crichton, R.) 22–70 (Wiley, 2016).
Torti, S. V., Manz, D. H., Paul, B. T., Blanchette-Farra, N. & Torti, F. M. Annu. Rev. Nutr. 38, 97–125 (2018).
Daniels, T. R. et al. Biochim. Biophys. Acta 1820, 291–317 (2012).
Pinnix, Z. K. et al. Sci. Transl. Med. 2, 43ra56 (2010).
Gu, Z. et al. Cancer Res. 75, 2211–2221 (2015).
Trujillo-Alonso, V. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-019-0406-1 (2019).
Balakrishnan, V. S. et al. Eur. J. Clin. Invest. 39, 489–496 (2009).
Vadhan-Raj, S. et al. Am. J. Hematol. 89, 7–12 (2014).
Zanganeh, S. et al. Nat. Nanotechnol. 11, 986–994 (2016).
Schoenfeld, J. D. et al. Cancer Cell 32, 268 (2017).
Kalinowski, D. S. et al. Biochim. Biophys. Acta 1863, 727–748 (2016).
Toth, G. B. et al. Kidney Int. 92, 47–66 (2017).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Torti, S.V., Torti, F.M. Winning the war with iron. Nat. Nanotechnol. 14, 499–500 (2019). https://doi.org/10.1038/s41565-019-0419-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-019-0419-9
- Springer Nature Limited